dual targeting anti-PD-1/TIM-3 mAbs (TESARO)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedual targeting anti-PD-1/TIM-3 mAbs (TESARO)
Drug Alias Namedual PD-1 checkpoint inhibitor/TIM-3 checkpoint inhibitor (TESARO)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockersHepatitis A virus cellular receptor 2 inhibitors
TargetsHepatitis A virus cellular receptor 2Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnaptysbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnaptysbio IncTesaro Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A